Realizing Rare Opportunities

AGM '14 Logo How appropriate that GLOBALHealthPR Australia partner VIVA! Communications chose Alexion’s David Kwasha to share his personal and Company views on rare diseases on World Rare Disease Day during our two-day annual general meeting in Sydney, Australia last week.

He challenged our group of leading, independent health-focused public relations firms to do more to advance the cause of rare diseases, and in particular, ultra-rare diseases.

In the U.S., a rare disease affects fewer than 200,000 persons, and an ultra-rare disease, fewer than 6,000.

David seemed happy to know that GLOBALHealthPR has already supported the location and identification of nearly 100 percent more children with Progeria, most definitely an ultra-rare disease in which children age rapidly. To date, about 110 children have been identified living with Progeria, an increase from 50 or so just five years ago. We titled our campaign “Find the other 150” because at the time, about 200 Progeria children were estimated worldwide. [Read more...]

Sam Berns, 1996-2014

John Seng is Founder & CEO of Spectrum and Chair of GLOBALHealthPR.Sam-alone

When I founded Spectrum in July 1996, I had no way of knowing that in October that same year a baby boy born to a Massachusetts couple would before too long enter my world, altering the life of my company, and before long the perspectives of anyone who crossed paths with him.

This baby’s name was Sampson Berns. His parents, physicians Leslie Gordon and Scott Berns, gave him the name of the biblical character who symbolized strength and invulnerability, but for the loss of his hair. Little did anyone appreciate at the time the sheer force of magnitude that baby Sam Berns would usher into our domain. [Read more...]

Help us Find the Other 150

Meet Ontlametse, left, from South Africa; Alicia, center, a PRF Ambassador; and Rafaely, right, from Brazil.

The Find the Other 150 Campaign is a joint Progeria Research Foundation and GLOBALHealthPR collaboration to locate the remaining 150 of the estimated 200-250 children living globally with Progeria.

Beginning in July and through the next several months, approximately 40 children from around the world will travel to Boston, Mass., in the United States to participate in the Triple Drug Trial, the latest clinical trial to test potential treatments for Progeria. To mark this expansion, The Progeria Research Foundation (PRF) is re-launching its highly successful “Find the Other 150” campaign to locate the remaining unidentified children living around the world with Progeria. [Read more...]